MLM Medical Labs is a Central Laboratory dedicated exclusively to clinical trials. MLM offers full laboratory services, including a whole range of analytics: standard safety profiles, such as blood counts, coagulation, urinalysis and clinical chemistry, and analyses of biomarkers, drug compounds, metabolites and molecular diagnostic parameters.
Location: Germany, North Rhine-Westphalia, Dusseldorf
Investors 2
| Date | Name | Website |
| - | Great Poin... | gppfunds.c... |
| - | Migration ... | migrationc... |
Mentions in press and media 11
| Date | Title | Description |
| 04.03.2026 | Cytespace Africa Laboratories Expands to Drive Cost-Efficient Clinical Trials Across Sub-Saharan Africa | New infrastructure strengthens Africa-based clinical trial logistics, reducing costs and accelerating timelines for global sponsors across Sub-Saharan Africa The future of research in Africa needs strong local infrastructure. In-region capa... |
| 03.11.2025 | MLM Medical Labs Validates Lumipulse® G pTau217/Beta-Amyloid 1-42 Plasma Ratio Assay Under IVDR/LDT Framework | First central lab in EU to perform this blood-based assay under IVDR/LDT regulations, supporting inclusion and exclusion criteria in Alzheimer’s clinical trials Achieving IVDR validation for the Lumipulse assay is an important milestone tha... |
| 03.06.2025 | MLM Medical Labs Acquires Cytespace Africa Laboratories, Expanding Global Reach into Africa's Clinical Research Market | We are thrilled to welcome Cytespace into the MLM family. Cytespace’s deep expertise and established presence make them the ideal partner to support this expanding landscape.” — Scott Houlton, CEOMöNCHENGLADBACH, NORTH RHINE-WESTPHALIA, GER... |
| 13.03.2025 | MLM Medical Labs Expands Infectious Disease and Women’s Health Molecular Testing Capabilities with Panther® Platform | Acquisition enhances MLM’s capacity for high-throughput, fully automated molecular diagnostics This investment aligns with our mission to provide leading-edge laboratory solutions that accelerate clinical and translational research.” — Scot... |
| 17.02.2025 | MLM Medical Labs - Germany Awarded 6th Consecutive CAP Accreditation for Service Excellence | “MLM Medical Labs is committed to delivering the highest quality, clinically actionable information and data to our clients in the clinical trials industry.” ” — Managing Director, Dr. Stephan VoswinkelMöNCHENGLADBACH, NORTH RHINE-WESTPHALI... |
| 08.07.2024 | MLM Medical Labs Announces Hiring of VP of Business Development & Marketing - U.S. in Response to Record Growth | Theresa Heath is a seasoned commercial leader with deep industry experience and consultative expertise that she brings to MLM's global business development and marketing team.” — Scott Houlton, CEOMEMPHIS, TN, UNITED STATES, July 8, 2024 /E... |
| 02.07.2024 | MLM Medical Labs Poised for Growth with Facilities Expansion in Mönchengladbach | MLM Medical, a global leader in central lab services, is pleased to announce the expansion of its facilities in Germany to support its growing operations. We’re very excited about this expansion of the MLM campus. The additional space is mu... |
| 29.05.2024 | MLM Receives S2 Lab Designation to Expand Support of the Rapidly Developing Cell & Gene Therapy Market | Today, we have significantly broadened our research horizons, enabling us to explore novel therapies for our clients globally in research involving GMOs.” — Scott Houlton, CEOMÖNCHENGLADBACH, NORTH RHINE-WESTPHALIA, GERMANY, May 29, 2024 /E... |
| 07.08.2023 | High Throughput Technology Enhances and Accelerates Research: MLM Medical Labs Acquires Leica Bio Aperio GT-450 Scanner | *leicabiosystems.com The acquisition of this state-of-the-art digital pathology technology marks a significant expansion to MLM's histology / histopathology capabilities This cutting-edge technology will transform our laboratory’s operation... |
| 04.04.2023 | MLM Medical Labs - Germany Completes Successful FDA Assessment | MLM passed the assessment without any objections or findings. MLM’s proprietary systems provided easy access to all the detailed inquiries from the FDA and provided clear evidence of the testing data.” — Nicole Jansen-Paland, Head of Qualit... |
Show more